Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-L1 Gene Amplification”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Testing effectiveness (Phase 2)UnknownNCT05859477
What this trial is testing

Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer

Who this might be right for
Metastatic Gastric CancerPD-L1 Gene AmplificationFGFR2 Amplification
Kidney Cancer Research Bureau 23
Not applicableUnknownNCT05533086
What this trial is testing

PD-L1 PET Imaging in Patients With the Immunotherapy for Non-small Cell Lung Cancer

Who this might be right for
NSCLC Stage IVPD-L1 Gene Amplification
Xiaohua Zhu 20
Not applicableLooking for participantsNCT07618936
What this trial is testing

Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients

Who this might be right for
PD-L1 Gene MutationPD-L1 Gene AmplificationPD-L1-related Disease+1 more
Tianjin Medical University 500